IDENTIFICATION OF NOVEL HIGH-AFFINITY CYTOPLASMIC ASPARAGINYL-TRNA SYNTHETASE INHIBITORS USING DOCKING AND MOLECULAR SIMULATION
Lymphatic filariasis is an endemic disease affecting humans in more than 83 countries, and it is crucial to find drugs to cure this disease. Nearly
1.33 billion were at risk of filariasis. In this study, we have targeted Brugia malayi asparaginyl tRNA synthetase (AsnRS) for new drug development against
filariasis. AsnRS is an essential enzyme for protein synthesis in nematodes and required at various steps of their life cycle. We used computational tools
for identifying potential molecule which can act as an inhibitor for our target AsnRS. 4133 molecules were selected after screening using Zinc Pharmer
and were docked in high throughput manner using vina and top 10% highest scoring molecules were selected. These molecules were re-docked, and
only those molecules were selected which shows less than 2Ã… root-mean-square deviation difference in the top pose predicted by both Autodock4 and
Autodock Vina. We identified 11 molecules fitting these criteria which were further subjected to interaction analysis. Molecular dynamics simulations
were performed on molecules showing best interaction based on their binding energy and hydrogen bond formation. It was seen that these molecules
were bound tightly inside the active site of the receptor. These molecules seem a suitable candidate to undergo in vitro testing.
Keywords: Docking, Filariasis, Virtual screening, asparaginyl tRNA synthetase.
1. Lustigman S, Prichard RK, Gazzinelli A, Grant WN, Boatin BA, McCarthy JS, et al. A research agenda for helminth diseases of humans: The problem of helminthiases. PLoS Negl Trop Dis 2012;6(4):e1582.
2. FÃ¨vre EM, Wissmann BV, Welburn SC, Lutumba P. The burden of human African trypanosomiasis. PLoS Negl Trop Dis 2008;2(12):e333.
3. Prichard RK, BasÃ¡Ã±ez MG, Boatin BA, McCarthy JS, GarcÃa HH, Yang GJ, et al. A research agenda for helminth diseases of humans: Intervention for control and elimination. PLoS Negl Trop Dis 2012;6(4):e1549.
4. Ibba M, Soll D. Aminoacyl-tRNA synthesis. Annu Rev Biochem 2000;69:617-50.
5. Jackson KE, Habib S, Frugier M, Hoen R, Khan S, Pham JS, et al. Protein translation in plasmodium parasites. Trends Parasitol 2011;27(10):467-76.
6. Pham JS, Dawson KL, Jackson KE, Lim EE, Pasaje CF, Turner KE, et al. Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites. Int J Parasitol 2014;4(1):1-13.
7. Nilsen TW, Maroney PA, Goodwin RG, Perrine KG, Denker JA, Nanduri J, et al. Cloning and characterization of a potentially protective antigen in lymphatic filariasis. Proc Natl Acad Sci U S A 1988;85(10):3604-7.
8. Kron M, Petridis M, Milev Y, Leykam J, HÃ¤rtlein M. Expression, localization and alternative function of cytoplasmic asparaginyl-tRNA synthetase in Brugia malayi. Mol Biochem Parasitol 2003;129(1):33-9.
9. Ahel I, Korencic D, Ibba M, SÃ¶ll D. Trans-editing of mischarged tRNAs. Proc Natl Acad Sci U S A 2003;100(26):15422-7.
10. Ali V, Nozaki T. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by â€œamitochondriateâ€ protozoan parasites. Clin Microbiol Rev 2007;20(1):164-87.
11. Koes DR, Camacho CJ. Zinc Pharmer: Pharmacophore search of the ZINC database. Nucleic Acids Res 2012;40(Web Server issue):W409-14.
12. Crepin T, Peterson F, Haertlein M, Jensen D, Wang C, Cusack S, et al. A hybrid structural model of the complete Brugia malayi cytoplasmic asparaginyl-tRNA synthetase. J Mol Biol 2011;405(4):1056-69.
13. Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG. ZINC: A free tool to discover chemistry for biology. J Chem Inf Model 2012;52(7):1757-68.
14. Trott O, Olson AJ. Auto dock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010 30;31(2):455-61.
15. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. Autodock4 and auto dock tools4: Automated docking with selective receptor flexiblity. J Comput Chem 2009;16(16):2785-91.
16. Houston DR, Walkinshaw MD. Consensus docking: Improving the reliability of docking in a virtual screening context. J Chem Inf Model 2013;53(2):384-90.
17. Ferrara P, Gohlke H, Price DJ, Klebe G, Brooks CL 3rd. Assessing scoring functions for protein-ligand interactions. J Med Chem 2004;47(12):3032-47.
18. Perola E, Walters WP, Charifson PS. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance. Proteins 2004;56(2):235-49.
19. Halperin I, Ma B, Wolfson H, Nussinov R. Principles of docking: An overview of search algorithms and a guide to scoring functions. Proteins 2002;47(4):409-43.
20. Stahl M, Rarey M. Detailed analysis of scoring functions for virtual screening. J Med Chem 2001;44(7):1035-42.
21. Bissantz C, Folkers G, Rognan D. Protein-based virtual screening of chemical databases 1. Evaluation of different docking/scoring combinations. J Med Chem 2000;43(25):4759-67.
22. Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 2006;65(3):712-25.
23. Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J Comput Chem 2004;25(9):1157-74.
24. Jakalian A, Jack DB, Bayly CI. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J Comput Chem 2002;23(16):1623-41.
25. Tejero R, Bassolino-Klimas D, Bruccoleri RE, Montelione GT. Simulated annealing with restrained molecular dynamics using CONGEN: Energy refinement of the NMR solution structures of epidermal and type-alpha transforming growth factors. Protein Sci 1996;5(4):578-92.
26. Dror RO, Dirks RM, Grossman JP, Xu H, Shaw DE. Biomolecular simulation: A computational microscope for molecular biology. Annu Rev Biophys 2012;41:429-52.
27. Lee EH, Hsin J, Sotomayor M, Comellas G, Schulten K. Discovery through the computational microscope. Structure 2009;17(10):1295-306.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.